Inventor
PERSONS PAUL E
US37 patents
⚠️ This page may combine multiple inventors who share the name “PERSONS PAUL E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SEPRACOR INC
15 patentsUS7294637B2Nov 13, 2007
Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
SEPRACOR INC89 citations97
US7132551B2Nov 7, 2006
Ligands for monoamine receptors and transporters, and methods of use thereof
SEPRACOR INC45 citations96
US6992077B2Jan 31, 2006
Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof
SEPRACOR INC43 citations96
US6476019B1Nov 5, 2002
Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof
SEPRACOR INC42 citations96
US6762177B2Jul 13, 2004
Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof
SEPRACOR INC41 citations92
US6699866B2Mar 2, 2004
Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof
SEPRACOR INC17 citations92
US7517892B2Apr 14, 2009
Ligands for monoamine receptors and transporters, and methods of use thereof
SEPRACOR INC8 citations84
US6548637B1Apr 15, 2003
Ligands for opioid receptors
SEPRACOR INC17 citations79
US6713479B2Mar 30, 2004
Piperidine-piperazine ligands for neurotransmitter receptors
SEPRACOR INC8 citations73
US7816375B2Oct 19, 2010
Ligands for monoamine receptors and transporters, and methods of use thereof
SEPRACOR INC4 citations62
US7511141B2Mar 31, 2009
Piperidine-piperazine ligands for neurotransmitter receptors
SEPRACOR INC1 citations62
US7087623B2Aug 8, 2006
Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof
SEPRACOR INC2 citations62
US6936614B2Aug 30, 2005
Piperidine-piperazine ligands for neurotransmitter receptors
SEPRACOR INC3 citations62
US7446115B2Nov 4, 2008
Peptidomimetic ligands for cellular receptors and ion channels
SEPRACOR INC0 citations52
US7115664B2Oct 3, 2006
Peptidomimetic ligands for cellular receptors and ion channels
SEPRACOR INC0 citations45
RHONE POULENC RORER PHARMA
12 patentsUSRE36256EJul 20, 1999
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
RHONE POULENC RORER PHARMA183 citations99
US5721237AFeb 24, 1998
Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
RHONE POULENC RORER PHARMA245 citations99
US5710158AJan 20, 1998
Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
RHONE POULENC RORER PHARMA339 citations99
US5656643AAug 12, 1997
Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
RHONE POULENC RORER PHARMA258 citations99
US5646153AJul 8, 1997
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
RHONE POULENC RORER PHARMA259 citations99
US5480883AJan 2, 1996
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
RHONE POULENC RORER PHARMA383 citations99
US5302606AApr 12, 1994
Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase
RHONE POULENC RORER PHARMA284 citations99
US5714493AFeb 3, 1998
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
RHONE POULENC RORER PHARMA176 citations98
US5409930AApr 25, 1995
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
RHONE POULENC RORER PHARMA314 citations97
US5795889AAug 18, 1998
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
RHONE POULENC RORER PHARMA59 citations96
US5476851ADec 19, 1995
Pyrazolo[3,4-g]quinoxaline compounds which inhibit PDGF receptor protein tyrosine kinase
RHONE POULENC RORER PHARMA25 citations91
US5677329AOct 14, 1997
Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit EGF receptor tyrosine kinase
RHONE POULENC RORER PHARMA15 citations82
AVENTIS PHARMA INC
4 patentsUS6524347B1Feb 25, 2003
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
AVENTIS PHARMA INC307 citations99
US6645969B1Nov 11, 2003
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
AVENTIS PHARMA INC74 citations95
US6846815B2Jan 25, 2005
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
AVENTIS PHARMA INC28 citations93
US7550597B2Jun 23, 2009
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
AVENTIS PHARMA INC0 citations52
AVENTIS PHARM PROD INC
2 patentsUS6159978ADec 12, 2000
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
AVENTIS PHARM PROD INC203 citations99
US6057320AMay 2, 2000
Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
AVENTIS PHARM PROD INC148 citations99